CLINICAL EVALUATION OF 1‐β‐D‐RIBOFURANOSYL‐1,2,4‐TRIAZOLE‐3‐CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE‐BLIND STUDY DURING AN OUTBREAK OF INFLUENZA

Francisco Salido‐Rengell; H. Nasser‐Quinones; Baltasar Briseño-Garcı́a

doi:10.1111/j.1749-6632.1977.tb21960.x

Back to search

CLINICAL EVALUATION OF 1‐β‐D‐RIBOFURANOSYL‐1,2,4‐TRIAZOLE‐3‐CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE‐BLIND STUDY DURING AN OUTBREAK OF INFLUENZA

Francisco Salido‐Rengell, H. Nasser‐Quinones, Baltasar Briseño-Garcı́a

DOI: 10.1111/j.1749-6632.1977.tb21960.x

Annals of the New York Academy of Sciences

Data up to Jan 2025

Published1977

Citations27

References8

Fields

Medicine Internal medicine Virology Gastroenterology

Total Citations Per Year

Abstract

References (8)

Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide

1972 • 967 citations

Antiviral Activity of 1-Adamantanamine (Amantadine)

1964 • 805 citations

Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

1972 • 459 citations

In Vitro Effect of 1-β- <scp>d</scp> -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid Viruses

1973 • 154 citations

SEROLOGICAL EVIDENCE FOR PREVENTION OF INFLUENZAL INFECTION IN VOLUNTEERS BY AN ANTI-INFLUENZAL DRUG ADAMANTANAMINE HYDROCHLORIDE.

1963 • 66 citations

Suppression by 1-β- <scp>d</scp> -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in Mice

1973 • 59 citations

Comparative Clinical and Laboratory Evaluation of the Prophylactic Capacity of Ribavirin, Amantadine Hydrochloride, and Placebo in Induced Human Influenza Type A

1976 • 56 citations

An Evaluation of a New Antiviral Agent “Virazole” against Influenza Virus Infections

1973 • 21 citations

Cited By (0)

Loading...